Barry Callebaut AG (BARN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 1,155.00 |
|---|---|
| 52-week range | 995.00 – 1,538.00 |
| Return, 1 month / 3 months | +3.5% / +5.3% |
| Return, 1 year / 3 years | −1.1% / −7.9% |
| Trend | Below its 200-day average |
| RSI (14) | 61 |
| Volatility (1 year) | 35.8% |
| Worst drawdown (1 year) | -32.0% |
| Average daily value traded | 11.56M CHF |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Barry Callebaut is a cocoa and chocolate manufacturer based in Switzerland. The company processes cocoa beans and makes chocolate, cocoa powder, cocoa butter and related ingredients, which it supplies to food manufacturers, confectioners, bakeries and other industrial customers around the world. Its business centres on producing these ingredients at scale for other companies that use them in their own products, rather than on selling branded chocolate directly to shoppers.
Barry Callebaut AG trades under the code BARN on the SIX Swiss Exchange in Switzerland, with its price quoted in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Barry Callebaut AG (BARN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 1,155.00 on 23 October 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 147 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.1% and over the last three months it rose 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.4% | ||
| From 52-week high | -24.2% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 5.3% | ||
| 6-month return | 2.8% | ||
| 12-month return, skipping the last month | -4.5% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.0% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 11.56M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | +3.5% |
| 3 months | +5.3% |
| 6 months | +2.8% |
| 1 year | −1.1% |
| 3 years | −7.9% |
| 5 years | −39.7% |
Signals
| 50-day / 200-day average | 1,106.84 / 1,207.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 29.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Jan 2026 | CHF 29.0000 |
| 7 Jan 2025 | CHF 29.0000 |
| 8 Jan 2024 | CHF 29.0000 |
| 9 Jan 2023 | CHF 28.0000 |
| 4 Jan 2022 | CHF 28.0000 |
| 5 Jan 2021 | CHF 22.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.